Japanese Phase 1 Multiple Ascending Dose (MAD) Study

NCT01396252 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Depression

Interventions

DRUG: BMS-820836
DRUG: BMS-820836
DRUG: BMS-820836
DRUG: Placebo matching BMS-820836
DRUG: BMS-820836

Sponsor

Bristol-Myers Squibb